Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Verve Therapeutics Inc (NQ: VERV ) 5.610 -0.010 (-0.18%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Verve Therapeutics Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > Verve Therapeutics: Q4 Earnings Insights February 27, 2024 Via Benzinga Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results February 27, 2024 From Verve Therapeutics Via GlobeNewswire 3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential February 19, 2024 Biotech stocks, namely those involved with gene editing, have been explosive and could see higher highs with strong catalysts. Via InvestorPlace 3 Gene Editing Stocks With Unprecedented Surge Potential February 13, 2024 While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential. Via InvestorPlace 2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare February 12, 2024 It's less scary to take on risky investments when the market is rising. Via The Motley Fool Why Verve Therapeutics Stock Crashed as Much as 30% This Week November 17, 2023 There was a concerning development in the company's clinical trials. Via The Motley Fool After Its Stock Crashed 42% in 1 Day, Is Verve Therapeutics a Buy? November 16, 2023 It reported some very bad news, but the market might be overreacting. Via The Motley Fool Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference February 01, 2024 From Verve Therapeutics Via GlobeNewswire 3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential January 31, 2024 Some of the top gene-editing stocks have had immense surge potential. Look at CRISPR Therapeutics, for example. Via InvestorPlace Why Beam Therapeutics Stock Zoomed 17% Higher Today January 29, 2024 JPMorgan Chase becomes the latest institution in the company's bull pen. Via The Motley Fool 7 Mighty Healthcare Stocks Changing the Game of Medicine January 17, 2024 Thanks to the permanent relevance of medical innovations, investors ought to consider looking at these healthcare stocks. Via InvestorPlace 3 Stocks to Buy in the Booming Field of Gene Editing January 11, 2024 As the promise of gene editing moves closer to being a reality, these gene editing stocks have the opportunity for long-term gains. Via InvestorPlace Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 January 05, 2024 Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. Via Investor's Business Daily Verve Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 02, 2024 From Verve Therapeutics Via GlobeNewswire 2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics December 31, 2023 Curing rare inherited illnesses could be a lucrative business model. Via The Motley Fool $18M Bet On Verve Therapeutics? Check Out These 3 Stocks Insiders Are Buying December 06, 2023 Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades. Via Benzinga You Don't Have to Pick a Winner in Gene-Editing. Do This Instead. December 04, 2023 The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach. Via The Motley Fool Verve Therapeutics Announces Closing of Public Offering of Common Stock, Full Exercise by Underwriters of Option to Purchase Additional Shares and Closing of Concurrent Private Placement December 01, 2023 From Verve Therapeutics Via GlobeNewswire Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 29, 2023 Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS... Via Benzinga Why Verve Therapeutics Stock (VERV) Is Falling November 29, 2023 Verve Therapeutics Inc (NASDAQ: VERV) shares are trading lower by 6.3% to $11.18 Wednesday morning after the company priced its proposed public offering of common stock and Via Benzinga Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket November 29, 2023 Shares of Workday, Inc. (NASDAQ: WDAY) surged in pre-market trading after the company reported upbeat earnings results for its third quarter. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 29, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday November 29, 2023 Pre-market stock movers are a good way to start the day as we dive into the biggest news worth checking out on Wednesday morning! Via InvestorPlace Leslie's Posts Weak Earnings, Joins Las Vegas Sands, Verve Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session November 29, 2023 U.S. stock futures traded higher this morning, with the Dow Jones futures gaining around 100 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement November 28, 2023 From Verve Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session November 28, 2023 Via Benzinga Verve Therapeutics Announces Proposed Public Offering of Common Stock and Concurrent Private Placement November 28, 2023 From Verve Therapeutics Via GlobeNewswire Verve Therapeutics: Why Great Results Aren't Enough November 16, 2023 The company's twist on CRISPR appears to work as intended but that didn't stop this biotech's stock price from collapsing. Via The Motley Fool 12 Health Care Stocks Moving In Tuesday's Intraday Session November 14, 2023 Via Benzinga Crude Oil Gains Over 1%; US Budget Deficit Narrows For October November 13, 2023 U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 50 points on Monday. The Dow traded up 0.16% to 34,337.33 while the NASDAQ fell 0.11% to 13,783.41. The S&P 500... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.